Psilocybin in serious illness: James Downar, Ali John Zarrabi and Margaret Ross
05/13/25 at 03:00 AM
Psilocybin in serious illness: James Downar, Ali John Zarrabi and Margaret Ross
GeriPal podcast; by Eric Widera, Alex Smith, James Downar, Ali John Zarrabi, Margaret Ross; 5/8/25
We’ve covered psychedelics on the podcast before — first in 2019 with Ira Byock, where we explored their potential role in medicine, and then again in 2023 with Stacy Fischer, Brian Anderson, and Theora Cimino, focusing on the reasons to approach psychedelic use in patients with caution. In today’s episode, we’re taking a closer look at the current state of the science around one specific psychedelic: psilocybin. We’ll discuss three recent clinical trials involving patients with serious illness, joined by our guests James Downar, Ali John Zarrabi, and Margaret Ross.